Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 1/20 | 0.31 |
| ▸ | GABRD | O14764 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.31 |
| ▸ | GABRE | P78334 | 1/20 | 0.31 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.31 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.31 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.31 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL201808 | 0.95 | ALOX5 (0.34) | TYR | |
| SCHEMBL202225 | 0.95 | ALOX5 (0.34) | TYR | |
| SCHEMBL201151 | 0.90 | ESR1 (0.32) | — | |
| SCHEMBL199546 | 0.84 | GABRP (0.31) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL199840 | 0.83 | TYR (0.33) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL201807 | 0.82 | ALOX5 (0.33) | TYR | |
| SCHEMBL202224 | 0.82 | ALOX5 (0.33) | TYR | |
| SCHEMBL201239 | 0.81 | CNR2 (0.33) | — | |
| SCHEMBL199937 | 0.81 | ALOX5 (0.37) | TYR | |
| SCHEMBL199973 | 0.81 | ALOX5 (0.37) | TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10230023-B2 | Color converter | BASF SE (DE) | 2019-03-12 | — | — | US | disclosed |
| EP-2718395-B1 | Novel illumination device comprising a colour converter | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-20160284947-A1 | NOVEL COLOR CONVERTER | BASF SE (DE) | 2016-09-29 | — | — | US | disclosed |
| US-9406848-B2 | Color converter | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| EP-2307507-B1 | NEW AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | BASF SE (DE) | 2016-04-20 | — | — | EP | disclosed |
| EP-1917311-B1 | Rylene based multiple chromophores | BASF SE (DE) | 2015-09-23 | — | — | EP | disclosed |
| US-8921558-B2 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | BASF SE (DE) | 2014-12-30 | — | — | US | disclosed |
| US-8802852-B2 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | BASF SE (DE) | 2014-08-12 | — | — | US | disclosed |
| US-20140080220-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | BASF SE (DE) | 2014-03-20 | — | — | US | disclosed |
| US-20140073059-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | BASF SE (DE) | 2014-03-13 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| WO-2009013258-A1 | USE OF RYLENE DERIVATIVES AS ACTIVE COMPONENTS IN SOLAR CELLS AND PHOTODETECTORS | BASF SE (DE) | 2009-01-29 | — | — | WO | disclosed |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080245411-A1 | Fluorescent Solar Conversion Cells Based on Fluorescent Terylene Dyes | BASF SE | 2008-10-09 | — | — | US | disclosed |
| US-20080167467-A1 | Substituted Rylene Derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| EP-1927141-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2008-06-04 | — | — | EP | disclosed |
| EP-1904497-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007031446-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2007-03-22 | — | — | WO | disclosed |
| WO-2007006717-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167467-A1 | Substituted Rylene Derivatives | NR3C2, NR2C2, NR2E3 | GABRP 1928/4885GABRD 1048/4885GABRA1 994/4885 |
| US-20140080220-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | NANS, NANP, GNE | GABRP 4064/4885GABRD 3451/4885GABRA1 3121/4885 |
| US-20140073059-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | NANS, NANP, GNE | GABRP 4064/4885GABRD 3451/4885GABRA1 3121/4885 |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | TDO2, PPOX, NPY1R | GABRP 1867/4885GABRD 2787/4885GABRA1 2209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.